Show results for
Refine by
Spike Protein Suppliers Serving Denmark
34 companies found
based inWuhan, CHINA
Wuhan Healthcare Biotechnology Co., Ltd. (Healthcare) is specialized in the production of high quality in vitro diagnostic reagents and instrumentation products that empower clinicians to treat patients faster than before and intended for hospitals, ...
For qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in serum, plasma (EDTA, sodium citrate and lithium heparin) or fingerstick whole blood, venous whole blood specimens from patients suspected of COVID-19 ...
based inBurlingame, CALIFORNIA (USA)
Using our vast experience, we were able to synthesize the human AGRP (83-1321) NH2 peptide. This product proved to be a potent inhibitor of MC3-R and MC4-R function. Another innovation tor Phoenix Pharmaceuticals, as we were first-to-market with ...
Molecular Weight: 5752.52, Purity: ≥ 90%, Validation: Exhibits correct molecular weight, Storage: Up to 6 months in lyophilized form at 0-5ºC. For best results, rehydrate just before use. After rehydration, keep solution at +4ºC for up ...
based inChatham, NEW JERSEY (USA)
Tonix is a clinical-stage biopharmaceutical company focused on developing novel therapies and vaccines to prevent and treat central nervous system disorders, immunology conditions, infectious diseases, and rare diseases. At Tonix, we are focused on ...
TNX-1850 is the planned new version of the TNX-1800 vaccine that encodes spike protein from SARS-CoV-2 BA.2 ...
based inMedford, MASSACHUSETTS (USA)
Seventh Sense Biosystems is enhancing lives by improving the blood collection experience and expanding safe access. Seventh Sense Biosystems is an innovative medical device company advancing disruptive, cutting-edge approaches to the way we draw ...
Antibodies can help measure your body’s response to vaccination or COVID-19 infection. Use this test to virtually painlessly measure the amount of spike (S) protein antibodies in your blood from the ...
based inCambridge, UNITED KINGDOM
Our business is organised to deliver our strategic priorities sustainably, supporting continued scientific innovation and commercial success. We focus on the discovery, development and commercialisation of prescription medicines in Oncology and ...
IVX-411 targets SARS-CoV-2, the coronavirus that causes COVID-19. Developed using cutting-edge structure-based design techniques at the Institute for Protein Design at the UW School of Medicine, IVX-411, our lead vaccine candidate ...
based inLondon, UNITED KINGDOM
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of patient and tumor heterogeneity. We use proprietary therapeutic ...
Using our proprietary computational vaccine design technology, we have developed a PolyPEPI preventive peptide vaccine against COVID-19 (SARS-CoV-2). The design of PolyPEPI-SCoV-2 exploits our knowledge on genetic heterogeneity of individuals ...
based inWurzburg, GERMANY
Virion\Serion, founded in 1978, is a company that has evolved over the last 40 years into a well-known and respected IVD manufacturer with one of the largest infectious disease portfolios for diagnosis of viral, bacterial, fungal and parasitic ...
Sometimes we are confronted with extreme situations that require extraordinary solutions. Our new product line supports in such situations and offers qualitative and quantitative immunoassays for the detection of human antibodies directed against ...
based inRedwood City, CALIFORNIA (USA)
Meissa Vaccines was founded with a mission to protect people everywhere from deadly respiratory viruses and a commitment to develop innovative technologies capable of delivering effective vaccines at a global scale. Meissa is developing live ...
The attenuation of a virus to produce a vaccine must balance reducing its virulence while retaining its ability to stimulate an effective immune response, or immunogenicity. Natural RSV infection does not stimulate a robust immune response, and ...
based inPaoli, NEW JERSEY (USA)
Beta Lifescience is a professional biotech company committed to providing premium quality life science research reagents worldwide across research and diagnostic markets. Our strong portfolio of recombinant proteins, viral antigens, antibodies, ...
Anti-Spike RBD Protein of SARS-CoV-2 (2019-nCoV/Wuhan), Mouse Monoclonal ...
based inVirum, DENMARK
Immudex was created in 2009 when it spun off from the diagnostic company Dako, now Agilent. Since then, Immudex has grown in numbers, employees, patents, product lines, partnerships, and customers served. Research, development, and commercial ...
Reliable Identification of SARS-CoV-2-Specific T-Cell Responses. T Cells Take the Lead in COVID-19. A deeper understanding of viral-specific T-cell responses to COVID-19 is needed to explore vaccine responses, long-term immunity, predict patients at ...
based inFramingham, MASSACHUSETTS (USA)
Kephera Diagnostics is a startup that aims to address the public health challenges of global infectious diseases with point of care assay technology. We collaborate with a global community of researchers to develop and translate new technologies ...
The COVI-QUANT™ test will give you an answer. It represents the latest generation of testing technology that will provide a numerical value for your antibody level, not just yes or no. COVI-QUANT™ is an ELISA test available through ...
based inStanmore, UNITED KINGDOM
Acellera’s mission is to accelerate the transition to rational, computerized drug discovery via simulations and machine learning. In order to fulfill this vision, we work with our customers by becoming a key technology partner, boosting their ...
based inBalerna, SWITZERLAND
PRIMA Lab SA, modern Swiss Company in the diagnostic field, develops the core of its innovation offering simple and efficient devices CE certified, for a quick check-up of human and animal’s health conditions. Thanks to its complete range of tests, ...
COVID-19 Neutralising IgG Serological Test is a rapid device which verifies the presence of COVID-19 neutralising IgG antibodies in human blood samples produced after the end of the vaccination cycle. ...
based inBoldon Colliery, UNITED KINGDOM
Immunodiagnostic Systems Holdings Ltd (hereafter referred to as IDS) is a leading in vitro diagnostic solution provider to the clinical laboratory market. We develop, manufacture and market innovative immunoassays and automated immunoanalyser ...
The Spike Protein Inhibition Assay (SPIA) is a competitive immunoenzymatic colorimetric method used for research purposes only to detect neutralising antibodies against SARS-CoV-2 in human ...
based inNantes, FRANCE
OSE Immunotherapeutics is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases. Based in Nantes (Head Office) and Paris, OSE Immunotherapeutics ...
CoVepiT, a multi-target and multi-variant vaccine candidate against COVID-19. CoVepiT is a next-generation multi-target, multi-variant vaccine against SARS-CoV-2 in clinical Phase 1. The vaccine candidate was designed using optimized epitopes ...
based inPeachtree Corners, GEORGIA (US) (USA)
RayBiotech is a leading life sciences company providing proteomic discovery tools. RayBiotech has nearly 150 employees whose objectives are to provide excellent products and service worldwide to RayBiotech customers which include scientists in ...
The SARS-CoV-2 Spike Protein Overlapping Peptide Array is semi-quantitative array displaying 316 synthesized peptides representing the full-length SARS-CoV-2 Spike protein ...
based inTainan City, TAIWAN
Leadgene Biomedical Inc. is founded in 2013 and headquarters in Tainan, Taiwan. In the past years, we have become an all-around solution provider for proteomics study with more than thirty staff members from a three-scientists workshop, ...
The neutralizing antibody blocks the interaction between RBD and ACE2. The uncut sheet must be further cut into individual strips. (Test line: spike ...
based inGeumcheon-gu, SOUTH KOREA
Since KogeneBiotech was founded in 2000, and our company has earned a reputation for innovation in Molecular Diagnostics. Our main business units are the production of Real-time PCR/conventional assay based on the active R&D works and testing ...
The SARS-CoV-2 variants can not only interrupt the formation of herd immunity through vaccination, but also the prevention and efficacy of the medical treatment. ...
based inBelfast, UNITED KINGDOM
Biopanda Reagents develops and manufactures in vitro test kits for clinical laboratories, veterinary practice, environmental protection, and food safety, both locally and globally. Our company provides innovative, high quality and cost-effective ...
The Biopanda COVID-19 RBD IgG Rapid Test Kit is a highly sensitive, qualitative lateral flow immunochromatographic assay for the detection of specific anti-Receptor Binding Domain (RBD) IgG antibodies to SARS-CoV-2 in human whole blood, serum or ...
based inExeter, UNITED KINGDOM
Attomarker is a British company focused on nanophotonic biochemical testing. It was founded in 2008, and spun out from Professor Andrew Shaw’s research group at the University of Exeter. It has won numerous prestigious awards for innovation and been ...
The following single-chip panels are available for the Liscar 6 platform. Additional panels will be highlighted here as they come on stream so please check back regularly or get in touch so that we can notify you when new panels are released. ...
